Sanofi, DNDi seek EMA review for sleeping sickness drug
Sanofi has asked European regulators to review an experimental medicine being developed in partnership with the Drugs for Neglected Disease initiative (DNDi) for sleeping sickness, which is endemic in Africa.
Read More
